As per Intent Market Research, the Virus Filtration Market was valued at USD 3.0 billion in 2024-e and will surpass USD 17.0 billion by 2030; growing at a CAGR of 33.8% during 2025 - 2030.
The Virus Filtration Market is driven by the increasing need for contamination-free products in biopharmaceuticals, vaccines, blood plasma products, and other healthcare applications. Virus filtration plays a critical role in ensuring the safety and quality of biological products by removing potentially harmful viruses, bacteria, and other pathogens during production processes. This filtration process is widely used in the production of vaccines, blood products, and therapeutic proteins, where the risk of viral contamination is high. The market is expected to grow rapidly due to rising concerns over the safety of biopharmaceuticals, increasing regulatory standards, and the growing demand for advanced filtration technologies across industries.
With the advancement in filtration technology, various types of virus filtration products are available in the market, including virus filtration membranes, filters, and kits. The use of these filtration solutions extends across several applications, such as blood plasma purification, vaccine manufacturing, and cell culture media filtration, ensuring the removal of viruses and other harmful microorganisms. The market is also benefiting from innovations in virus filtration systems that increase efficiency, reduce costs, and improve the safety and quality of biopharmaceutical products.
Virus Filtration Membranes Segment is Largest Owing to Widespread Use in Biopharmaceuticals
The virus filtration membranes segment is the largest in the Virus Filtration market, primarily due to the widespread adoption of membrane-based filtration solutions in biopharmaceuticals and vaccine manufacturing. These membranes are designed to selectively filter out viruses and other contaminants while allowing the passage of target molecules, making them ideal for use in critical applications where maintaining the integrity of the biological product is essential. Membrane filters offer high efficiency, ease of use, and scalability, which makes them the preferred choice in large-scale manufacturing processes, such as in the production of therapeutic proteins and vaccines.
In addition to biopharmaceuticals, virus filtration membranes are also widely used in blood plasma purification and water and beverage filtration applications. The ability to customize membrane filters for specific viruses and contaminants, as well as their ability to function across a broad range of flow rates and operating conditions, are key factors contributing to the dominance of this segment. As the demand for safer blood products and vaccines increases, the market for virus filtration membranes is expected to remain strong, supported by advancements in filtration technology and the increasing adoption of membrane-based solutions across various industries.
Virus Filtration Kits Segment is Fastest Growing Due to Increasing Demand for On-Site Testing and Convenience
The virus filtration kits segment is the fastest growing in the Virus Filtration market, driven by the increasing demand for on-site testing solutions and the convenience offered by ready-to-use kits. Virus filtration kits provide a comprehensive solution for laboratories and healthcare facilities by combining virus filters, collection tubes, and other necessary components in a single, easy-to-use package. These kits enable rapid and efficient filtration, making them an attractive option for industries involved in vaccine production, blood product testing, and other sensitive applications.
As the need for quick, efficient virus filtration grows in response to public health concerns and regulatory requirements, especially following the COVID-19 pandemic, the demand for virus filtration kits has surged. These kits are particularly popular in settings where portability and flexibility are essential, such as research laboratories, hospitals, and testing facilities. Their ability to simplify virus filtration workflows and reduce the need for specialized equipment and training is expected to drive continued growth in this segment.
Biopharmaceuticals Segment is Largest End-Use Industry Due to High Demand for Virus-Free Therapeutics
The biopharmaceuticals segment is the largest end-use industry in the Virus Filtration market, driven by the growing demand for biopharmaceutical products that are free from viral contamination. Biopharmaceuticals include therapeutic proteins, monoclonal antibodies, and other biologics, all of which require stringent safety standards to ensure they are free from harmful pathogens. Virus filtration is critical in the production of these biologics to protect both patients and healthcare providers from the risks associated with viral transmission.
The increased demand for biologics, along with heightened regulatory scrutiny regarding viral contamination in therapeutic products, has significantly boosted the adoption of virus filtration solutions in the biopharmaceutical industry. The ability to effectively eliminate viruses from biologic drugs, especially in large-scale manufacturing processes, is a key factor driving the growth of this segment. As biopharmaceuticals continue to gain market share due to their efficacy in treating a wide range of diseases, the demand for virus filtration technologies will continue to increase in this sector.
North America is Largest Region Owing to Advanced Healthcare Infrastructure and Regulatory Standards
North America is the largest region in the Virus Filtration market, owing to its advanced healthcare infrastructure, stringent regulatory standards, and the high demand for biopharmaceuticals and vaccines. The United States, in particular, is a major player in the biopharmaceutical sector, with numerous pharmaceutical companies and research institutions focusing on the development of biologics, vaccines, and blood products. The region's well-established regulatory environment requires the implementation of rigorous safety standards, making virus filtration a critical component in the production of these products.
Additionally, the growing emphasis on improving the safety of healthcare products and the rising prevalence of chronic diseases are contributing to the strong demand for virus filtration solutions in North America. The region is also home to several key players in the virus filtration market, which further supports the growth of the industry. With continued advancements in technology and an increasing focus on patient safety, North America is expected to maintain its leadership position in the market.
Competitive Landscape
The Virus Filtration market is highly competitive, with several major players focusing on enhancing their product portfolios and expanding their geographic presence. Key companies in this market include Merck KGaA, Sartorius AG, GE Healthcare, Thermo Fisher Scientific, and Danaher Corporation. These companies are continuously innovating to develop more efficient and cost-effective virus filtration solutions, such as advanced membranes, filters, and kits, that meet the stringent requirements of the biopharmaceutical and vaccine industries.
The market is also witnessing strategic partnerships, acquisitions, and collaborations among industry players to strengthen their market position and expand their product offerings. With the increasing demand for virus-free biopharmaceutical products and the growing focus on improving healthcare safety standards, the competitive landscape is expected to become more dynamic. Companies are investing in research and development to introduce next-generation virus filtration technologies, which will play a crucial role in driving the growth of this market.
Recent Developments:
- Merck KGaA announced the launch of a new virus filtration membrane designed to improve the efficiency and safety of biopharmaceutical production.
- Pall Corporation introduced a next-generation virus filtration filter with enhanced virus removal capabilities for vaccine and biologics manufacturing.
- Sartorius AG expanded its virus filtration portfolio with a new range of filters for gene therapy applications, improving purification processes.
- Thermo Fisher Scientific partnered with a leading vaccine manufacturer to provide virus filtration solutions for COVID-19 vaccine production.
- Charles River Laboratories acquired a virus filtration technology company to enhance its offerings in the biopharmaceutical manufacturing and testing sectors.
List of Leading Companies:
- Merck KGaA
- Pall Corporation (Danaher Corporation)
- Sartorius AG
- Asahi Kasei Medical Co., Ltd.
- GE Healthcare
- Danaher Corporation
- Thermo Fisher Scientific
- Charles River Laboratories
- Fujifilm Irvine Scientific
- 3M
- MilliporeSigma (Merck Group)
- KUBOTA Corporation
- Lonza Group
- Cytiva (Formerly GE Healthcare Life Sciences)
- Bio-Rad Laboratories
Report Scope:
Report Features |
Description |
Market Size (2024-e) |
USD XX billion |
Forecasted Value (2030) |
USD XX billion |
CAGR (2025 – 2030) |
XX% |
Base Year for Estimation |
2024-e |
Historic Year |
2023 |
Forecast Period |
2025 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Global Virus Filtration Market by Type (Virus Filtration Membranes, Virus Filtration Filters, Virus Filtration Kits), by End-Use Industry (Biopharmaceuticals, Blood & Plasma Products, Vaccines and Gene Therapy), by Application (Blood Plasma Purification, Vaccine Manufacturing, Cell Culture Media Filtration, Water and Beverage Filtration) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Asahi Kasei Medical Co., Ltd., GE Healthcare, Danaher Corporation, Charles River Laboratories, Fujifilm Irvine Scientific, 3M, MilliporeSigma (Merck Group), KUBOTA Corporation, Lonza Group, Bio-Rad Laboratories. |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Virus Filtration Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030) |
4.1. Virus Filtration Membranes |
4.2. Virus Filtration Filters |
4.3. Virus Filtration Kits |
5. Virus Filtration Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
5.1. Biopharmaceuticals |
5.2. Blood & Plasma Products |
5.3. Vaccines and Gene Therapy |
5.4. Others |
6. Virus Filtration Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
6.1. Blood Plasma Purification |
6.2. Vaccine Manufacturing |
6.3. Cell Culture Media Filtration |
6.4. Water and Beverage Filtration |
6.5. Others |
7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
7.1. Regional Overview |
7.2. North America |
7.2.1. Regional Trends & Growth Drivers |
7.2.2. Barriers & Challenges |
7.2.3. Opportunities |
7.2.4. Factor Impact Analysis |
7.2.5. Technology Trends |
7.2.6. North America Virus Filtration Market, by Type |
7.2.7. North America Virus Filtration Market, by End-Use Industry |
7.2.8. North America Virus Filtration Market, by Application |
7.2.9. By Country |
7.2.9.1. US |
7.2.9.1.1. US Virus Filtration Market, by Type |
7.2.9.1.2. US Virus Filtration Market, by End-Use Industry |
7.2.9.1.3. US Virus Filtration Market, by Application |
7.2.9.2. Canada |
7.2.9.3. Mexico |
*Similar segmentation will be provided for each region and country |
7.3. Europe |
7.4. Asia-Pacific |
7.5. Latin America |
7.6. Middle East & Africa |
8. Competitive Landscape |
8.1. Overview of the Key Players |
8.2. Competitive Ecosystem |
8.2.1. Level of Fragmentation |
8.2.2. Market Consolidation |
8.2.3. Product Innovation |
8.3. Company Share Analysis |
8.4. Company Benchmarking Matrix |
8.4.1. Strategic Overview |
8.4.2. Product Innovations |
8.5. Start-up Ecosystem |
8.6. Strategic Competitive Insights/ Customer Imperatives |
8.7. ESG Matrix/ Sustainability Matrix |
8.8. Manufacturing Network |
8.8.1. Locations |
8.8.2. Supply Chain and Logistics |
8.8.3. Product Flexibility/Customization |
8.8.4. Digital Transformation and Connectivity |
8.8.5. Environmental and Regulatory Compliance |
8.9. Technology Readiness Level Matrix |
8.10. Technology Maturity Curve |
8.11. Buying Criteria |
9. Company Profiles |
9.1. Merck KGaA |
9.1.1. Company Overview |
9.1.2. Company Financials |
9.1.3. Product/Service Portfolio |
9.1.4. Recent Developments |
9.1.5. IMR Analysis |
*Similar information will be provided for other companies |
9.2. Pall Corporation (Danaher Corporation) |
9.3. Sartorius AG |
9.4. Asahi Kasei Medical Co., Ltd. |
9.5. GE Healthcare |
9.6. Danaher Corporation |
9.7. Thermo Fisher Scientific |
9.8. Charles River Laboratories |
9.9. Fujifilm Irvine Scientific |
9.10. 3M |
9.11. MilliporeSigma (Merck Group) |
9.12. KUBOTA Corporation |
9.13. Lonza Group |
9.14. Cytiva (Formerly GE Healthcare Life Sciences) |
9.15. Bio-Rad Laboratories |
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Virus Filtration Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Virus Filtration Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Virus Filtration Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA